HEALTH Under the supervision of Department of Health – Abu Dhabi, Burjeel Cancer Institute administers world-first precision therapy to patient with advanced breast cancer Abu Dhabi Media Office · 17 June 2026

Under the supervision of the Department of Health – Abu Dhabi, Burjeel Cancer Institute has administered Camizestrant, a next-generation therapy for advanced breast cancer, for the first time worldwide in a clinical care setting. The treatment supports earlier, more targeted intervention for patients whose cancer has developed resistance to conventional hormone therapy.